FDA advisers back Pfizer's maternal RSV vaccine after voicing safety concerns. Boytchev H. BMJ 2023;381:p1187.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Boytchev H. FDA advisers back Pfizer's maternal RSV vaccine after voicing safety concerns. BMJ 2023;381:p1187.
PMID: 37220918